UNICREDIT BANK/PUT/SARTORIUS STEDIM BIO/250/0.01/18.12.24 Share Price

Warrant

H250T

DE000HC8FEJ3

Market Closed - Euronext Paris 17:30:02 07/06/2024 BST
0.67 EUR +1.52% Intraday chart for UNICREDIT BANK/PUT/SARTORIUS STEDIM BIO/250/0.01/18.12.24
Current month-1.47%
1 month+31.37%
Date Price Change
07/06/24 0.67 +1.52%
06/06/24 0.66 0.00%
05/06/24 0.66 -7.04%
04/06/24 0.71 +1.43%
03/06/24 0.7 +2.94%

Real-time Euronext Paris

Last update June 07, 2024 at 05:30 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer UniCredit UniCredit
H250T
ISINDE000HC8FEJ3
Date issued 03/08/2023
Strike 250
Maturity 18/12/2024 (193 Days)
Parity 100 : 1
Emission price-
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.88
Lowest since issue 0.27
Delta-0.76x
Omega 2.084
Premium1.16x
Gearing2.74x
Moneyness 1.354
Difference Strike 65.35
Difference Strike %+26.14%
Spread 0.03
Spread %4.35%
Theoretical value 0.6750
Implied Volatility 44.38 %
Total Loss Probability 15.03 %
Intrinsic value 0.6535
Present value 0.0215
Break even 182.50 €
Theta-0x
Vega0x
Rho-0.01x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
184.6 EUR
Average target price
248.8 EUR
Spread / Average Target
+34.76%
Consensus
  1. Stock Market
  2. Warrants
  3. H250T Warrant
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW